HAYSTACK ONCOLOGY, INC.

Profile

Company Names

HAYSTACK ONCOLOGY, INC.

Addresses

301 W 29TH STREET, SUITE 2004U, BALTIMORE, MD 21211

Phone Numbers

4102971000

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$67,018,621.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-10-17 
$67,018,621.00 
$67,018,621.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAN 
 
EDELSTEIN 
EXECUTIVE OFFICER, DIRECTOR
HAYSTACK ONCOLOGY, INC.
OLGA 
 
MALTSEVA 
EXECUTIVE OFFICER
CATALIO CREDIT OPPORTUNITIES FUND I LP   |  HAYSTACK ONCOLOGY, INC.   |  CATALIO STRUCTURED OPPORTUNITIES FUND I LP   |  CATALIO PUBLIC EQUITIES FUND, LP   |  CATALIO PUBLIC EQUITIES OFFSHORE FUND, LTD.   |  CATALIO NEXUS FUND IV, LP   |  CATALIO STRUCTURED OPPORTUNITIES OFFSHORE FUND II, LP   |  CATALIO STRUCTURED OPPORTUNITIES FUND II, LP   |  CATALIO NEXUS OFFSHORE FUND IV, LP
NICKOLAS 
 
PAPADOPOULOS 
EXECUTIVE OFFICER, DIRECTOR
HAYSTACK ONCOLOGY, INC.
GEORGE 
 
PETROCHEILOS 
DIRECTOR
SISU GLOBAL HEALTH INC.   |  MIND-X CORP.   |  CATALIO CREDIT OPPORTUNITIES FUND I LP   |  HAYSTACK ONCOLOGY, INC.   |  CATALIO STRUCTURED OPPORTUNITIES FUND I LP   |  CATALIO PUBLIC EQUITIES FUND, LP   |  CATALIO PUBLIC EQUITIES OFFSHORE FUND, LTD.   |  CATALIO GENESIS FUND V, LLC   |  CATALIO ACCESS FUND VII, LLC   |  CATALIO NEXUS FUND IV, LP   |  CATALIO STRUCTURED OPPORTUNITIES OFFSHORE FUND II, LP   |  CATALIO STRUCTURED OPPORTUNITIES FUND II, LP   |  CATALIO NEXUS OFFSHORE FUND IV, LP   |  CATALIO INFLECTION FUND I, LLC   |  CATALIO GENESIS FUND VI, LLC   |  CATALIO GENESIS FUND VIII, LLC   |  CATALIO GENESIS FUND IX, LLC   |  CATALIO GENESIS FUND X, LLC   |  CATALIO ACCESS FUND X, LLC   |  CATALIO ACCESS FUND IX, LLC   |  CATALIO ACCESS FUND VIII, LLC   |  CATALIO INFLECTION FUND II, LLC   |  CATALIO INFLECTION FUND III, LLC   |  CATALIO ACCESS FUND XI, LLC
ISAAC 
 
RO 
DIRECTOR
HAYSTACK ONCOLOGY, INC.   |  PINKDX, INC.   |  CAGE PHARMACEUTICALS, INC.   |  PROGNOMIQ, INC.
R. JACOB 
 
VOGELSTEIN 
DIRECTOR
MIND-X CORP.   |  ENEURA, INC.   |  HAYSTACK ONCOLOGY, INC.   |  IAMBIC THERAPEUTICS, INC.   |  NEXTPOINT THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-11-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#